Advertisement
Screener

ARDEA BIOSCIENCES, INC./DE Patents: Applications Rejected

ARDEA BIOSCIENCES, INC./DE Patent Applications Rejected

26 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2020-12-16: Application 17123380; Invention THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE; Applicant ARDEA BIOSCIENCES, INC.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2019-10-14: Application 16601294; Invention CXCR-2 INHIBITORS FOR TREATING DISORDERS; Applicant ARDEA BIOSCIENCES, INC.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2019-01-14: Application 16246833; Invention Novel Compounds and Compositions and Methods of Use; Applicant Ardea Biosciences, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
  • 2018-12-13: Application 16218856; Invention Polymorphic Forms of 2-(5-Bromo-4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-Triazol-3-ylthio)Acetic Acid and Uses Thereof; Applicant Ardea Biosciences, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2020-12-1617123380THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USEARDEA BIOSCIENCES, INC.Abandoned -- Failure to Respond to an Office ActionUS20210171466A1
Samedy OUK
Esmir GUNIC
Jean-Michel VERNIER
Chixu CHEN
United States
United States
United States
United States
BORI, IBRAHIM D
2019-10-1416601294CXCR-2 INHIBITORS FOR TREATING DISORDERSARDEA BIOSCIENCES, INC.Abandoned -- Failure to Respond to an Office ActionUS20200281878A1
Payal NANAVATI
Johan HOEGSTEDT
Jesse HALL
United States
United States
United States
POLANSKY, GREGG
2019-01-1416246833Novel Compounds and Compositions and Methods of UseArdea Biosciences, Inc.Abandoned -- Incomplete Application (Pre-examination)US20190142805A1
Barry D. Quart
Jean-Luc Giradet
Esmir Gunic
Li-Tain Yeh
United States
United States
United States
United States
2018-12-1316218856Polymorphic Forms of 2-(5-Bromo-4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-Triazol-3-ylthio)Acetic Acid and Uses ThereofArdea Biosciences, Inc.Abandoned -- Incomplete Application (Pre-examination)US20190111028A1
Laszlo R. Treiber
Irina Zamansky
Jean-Luc Girardet
United States
United States
United States
2018-09-1916135153Treatment of Gout and HyperuricemiaArdea Biosciences, Inc.Abandoned -- Incomplete Application (Pre-examination)US20190015392A1
Jeffrey Miner
Barry D. Quart
Jean-Luc Girardet
United States
United States
United States
2018-04-2015958333Polymorphic Forms of 2-(5-Bromo-4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-Triazol-3-ylthio)Acetic Acid and Uses ThereofArdea Biosciences, Inc.Abandoned -- Incomplete Application (Pre-examination)US20180235939A1
Laszlo R. Treiber
Irina Zamansky
Jean-Luc Girardet
United States
United States
United States
2018-02-0815891727Methods for Treating Hyperuricemia and Related DiseasesArdea Biosciences, Inc.Abandoned -- Incomplete Application (Pre-examination)US20180161314A1
Barry D. Quart
United States
2018-01-2415878679Treatment of Gout and HyperuricemiaArdea Biosciences, Inc.Abandoned -- Incomplete Application (Pre-examination)
Jeffrey Miner
Barry D. Quart
Jean-Luc Girardet
United States
United States
United States
2017-09-1215702693CXCR-2 INHIBITORS FOR TREATING DISORDERSARDEA BIOSCIENCES, INC.Abandoned -- Failure to Respond to an Office ActionUS20180221312A1
Payal NANAVATI
Johan HOEGSTEDT
Jesse HALL
United States
United States
United States
POLANSKY, GREGG
2017-06-3015638828Methods for Treating Hyperuricemia and Related DiseasesArdea Biosciences, Inc.Abandoned -- Incomplete Application (Pre-examination)
Barry D. Quart
United States
2017-06-1615624818Treatment of Gout and HyperuricemiaArdea Biosciences, Inc.Abandoned -- Incomplete Application (Pre-examination)
Jeffrey Miner
Barry D. Quart
Jean-Luc Girardet
United States
United States
United States
2017-02-2315440722ATROPISOMERS OF TRIAZOLE DERIVATIVEARDEA BIOSCIENCES, INC.Abandoned -- Failure to Respond to an Office ActionUS20170319552A1
Matthew Kent RENNER
United States
CHENG, KAREN
2017-02-1615435119S-TRIAZOLYL ALPHA-MERCAPTO ACETANILIDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASEArdea Biosciences, Inc.Abandoned -- Failure to Respond to an Office ActionUS20180002296A1
Jean-Luc GIRARDET
Yung-Hyo KOH
Martha DE LA ROSA
Esmir GUNIC
Zhi HONG
Stanley LANG
Woo-Hong KIM
United States
United States
United States
United States
United States
United States
United States
SHAMEEM, GOLAM M
2016-08-0315227395DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEKARDEA BIOSCIENCES, INC.Abandoned -- Failure to Respond to an Office ActionUS20170183333A1
Andreas Maderna
Jean-Michel Vernier
Dinesh Barawkar
Varaprasad Chamakura
Hassan El Abdellaoul
Zhi Hong
United States
United States
United States
United States
United States
United States
CUTLIFF, YATE KAI RENE
2016-06-2415192193TREATMENT OF GOUTARDEA BIOSCIENCES, INC.Abandoned -- Failure to Respond to an Office ActionUS20160374993A1
Jeffrey MINER
Barry D. QUART
Jean-Luc GIRARDET
United States
United States
United States
HUI, SAN MING R
2016-04-0815094166NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USEArdea Biosciences, Inc.Expressly Abandoned -- During ExaminationUS20160221970A1
Barry D. QUART
Jean-Luc GIRARDET
Esmir GUNIC
Li-Tain YEH
United States
United States
United States
United States
SHAMEEM, GOLAM M
2016-02-1915048110MANUFACTURE OF 2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACIDARDEA BIOSCIENCES, INC.Abandoned -- Failure to Respond to an Office ActionUS20160214947A1
Esmir GUNIC
Gabriel GALVIN
United States
United States
CHENG, KAREN
2015-12-2314757583Compounds, compositions and methods of using same for modulating uric acid levelsArdea Biosciences, Inc.Abandoned -- Failure to Respond to an Office ActionUS20160221969A1
Esmir GUNIC
Jean-Luc GIRARDET
Jean-Michel VERNIER
Martina E. TEDDER
David A. PAISNER
United States
United States
United States
United States
United States
SHAMEEM, GOLAM M
2015-11-1214939963TREATMENT OF GOUT AND HYPERURICEMIAARDEA BIOSCIENCES, INC.Abandoned -- Failure to Respond to an Office ActionUS20160143889A1
Jeffrey MINER
Barry D. QUART
Jean-Luc GIRARDET
United States
United States
United States
TRAN, MY CHAU T
2015-05-1114708891COMBINATIONS OF MEK INHIBITORS AND RAF KINASE INHIBITORS AND USES THEREOFARDEA BIOSCIENCES, INC.Abandoned -- Failure to Respond to an Office ActionUS20160271122A1
Jeffrey N. MINER
Mark S. CHAPMAN
Barry QUART
Alex ADJEI
Chunrong YU
United States
United States
United States
United States
United States
STONE, CHRISTOPHER R
2014-12-1914577129POLYMORPHIC FORMS OF 2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID AND USES THEREOFArdea Biosciences, Inc.Abandoned -- Failure to Pay Issue FeeUS20150105410A1
Laszlo R. TREIBER
Irina ZAMANSKY
Jean-Luc GIRARDET
United States
United States
United States
AGUIRRE, AMANDA L
2014-12-0314559803S-TRIAZOLYL ALPHA-MERCAPTO ACETANILIDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASEArdea Biosciences, Inc.Abandoned -- Failure to Respond to an Office ActionUS20150094284A1
Jean-Luc GIRARDET
Yung-Hyo KOH
Martha DE LA ROSA
Esmir GUNIC
Zhi HONG
Stanley LANG
Woo-Hong KIM
United States
United States
United States
United States
United States
United States
United States
SHAMEEM, GOLAM M
2013-11-0814075684COMPOUNDS, COMPOSITIONS AND METHODS OF USING SAME FOR MODULATING URIC ACID LEVELSARDEA BIOSCIENCES, INC.Abandoned -- Failure to Respond to an Office ActionUS20140128338A1
Esmir GUNIC
Jean-Luc GIRARDET
Jean-Michel VERNIER
Martina E. TEDDER
David A. PAISNER
United States
United States
United States
United States
United States
SHAMEEM, GOLAM M
2013-08-1413967255POLYMORPHIC FORMS OF 2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID AND USES THEREOFArdea Biosciences, Inc.Abandoned -- Failure to Respond to an Office ActionUS20130331403A1
Laszlo R. TREIBER
Irina ZAMANSKY
Jean-Luc GIRARDET
United States
Canada
United States
AGUIRRE, AMANDA L
2013-07-3013954736POLYMORPHIC, CRYSTALLINE AND MESOPHASE FORMS OF SODIUM 2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO) ACETATE, AND USES THEREOFArdea Biosciences, Inc.Abandoned -- Failure to Respond to an Office ActionUS20130345271A1
Irina ZAMANSKY
Gabriel GALVIN
Jean-Luc GIRARDET
United States
United States
United States
HAVLIN, ROBERT H
2013-07-3013954730NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USEArdea Biosciences, Inc.Abandoned -- Failure to Respond to an Office ActionUS20140005136A1
Barry D. QUART
Jean-Luc GIRARDET
Esmir GUNIC
Li-Tain YEH
United States
United States
United States
United States
SHAMEEM, GOLAM M